Bristol-Myers Squibb Beats Expectations in Q3 as Its Celgene Acquisition Nears the Finish LineThe Motley Fool • 10/31/19
Why the Earnings Surprise Streak Could Continue for Celgene (CELG)Zacks Investment Research • 10/25/19